Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

37.50 +0.97 (+2.66%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,613,161
Open 36.95
Bid (Size) 36.38 (100)
Ask (Size) 37.39 (400)
Prev. Close 36.53
Today's Range 36.20 - 37.70
52wk Range 32.99 - 117.33
Shares Outstanding 115,926,629
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Scott+Scott Attorneys at Law LLP Reminds Investors of Its Investigation Into Corcept Therapeutics Incorporated (NASDAQ: CORT)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
News headline image
CORCEPT ALERT: Bragar Eagel & Squire, P.C. is Investigating Corcept Therapeutics Incorporated on Behalf of Corcept Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Performance

YTD
-1.8%
-1.8%
1 Month
-56.0%
-56.0%
3 Month
-49.3%
-49.3%
6 Month
-47.8%
-47.8%
1 Year
-24.8%
-24.8%

More News

Read More
News headline image
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
From Pomerantz LLP
Via GlobeNewswire
News headline image
1 Healthcare Stock to Target This Week and 2 We Turn Down
Via StockStory
Topics Stocks
News headline image
CORCEPT THERAPEUTICS is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
Via TheNewswire.com
News headline image
CORCEPT THERAPEUTICS is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
News headline image
Why Corcept (CORT) Stock Is Trading Lower Today
Via StockStory
News headline image
Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations
Via NewMediaWire
News headline image
Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations
Via TheNewswire.com
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
News headline image
Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Possible Securities Law Violations
Via NewMediaWire
News headline image
Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Possible Securities Law Violations
Via TheNewswire.com
Nasdaq, S&P 500 Futures Point To Strong New-Year Open On Wall Street: Why TSLA, BIDU, SLV, STLA Are On Traders' Radar Today ↗
Via Stocktwits
Topics Stocks
News headline image
Stocks making big moves yesterday: FuelCell Energy, Corcept, and PacBio
Via StockStory
News headline image
Kaplan Fox Announces an Investigation Into Corcept Therapeutics, Inc. (CORT) for Potential Securities Law Violations
Via TheNewswire.com
News headline image
Kaplan Fox Announces an Investigation Into Corcept Therapeutics, Inc. (CORT) for Potential Securities Law Violations
Via NewMediaWire
News headline image
Why Xeris Biopharma Stock Zoomed 7% Higher on Wednesday ↗
Via The Motley Fool
News headline image
Why Corcept Therapeutics Plummeted by 50% Today ↗
Via The Motley Fool
News headline image
Why Corcept (CORT) Shares Are Falling Today
Via StockStory
Here are the top movers in Wednesday's session. ↗
Via Chartmill
News headline image
Kaplan Fox & Kilsheimer LLP is Investigating Corcept Therapeutics, Inc. (CORT) for Potential Securities Law Violations
Via TheNewswire.com
News headline image
Kaplan Fox & Kilsheimer LLP is Investigating Corcept Therapeutics, Inc. (CORT) for Potential Securities Law Violations
Via NewMediaWire
Top movers analysis in the middle of the day on 2025-12-31: top gainers and losers in today's session. ↗
Via Chartmill
The market is filled with gapping stocks in Wednesday's session. ↗
Via Chartmill

Frequently Asked Questions

Is Corcept Therapeutics Incorporated - Common Stock publicly traded?
Yes, Corcept Therapeutics Incorporated - Common Stock is publicly traded.
What exchange does Corcept Therapeutics Incorporated - Common Stock trade on?
Corcept Therapeutics Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Corcept Therapeutics Incorporated - Common Stock?
The ticker symbol for Corcept Therapeutics Incorporated - Common Stock is CORT on the Nasdaq Stock Market
What is the current price of Corcept Therapeutics Incorporated - Common Stock?
The current price of Corcept Therapeutics Incorporated - Common Stock is 37.50
When was Corcept Therapeutics Incorporated - Common Stock last traded?
The last trade of Corcept Therapeutics Incorporated - Common Stock was at 01/09/26 04:00 PM ET
What is the market capitalization of Corcept Therapeutics Incorporated - Common Stock?
The market capitalization of Corcept Therapeutics Incorporated - Common Stock is 4.35B
How many shares of Corcept Therapeutics Incorporated - Common Stock are outstanding?
Corcept Therapeutics Incorporated - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.